Pharmacogenomics in Autism Treatment.

Trial Profile

Pharmacogenomics in Autism Treatment.

Completed
Phase of Trial: Phase II/III

Latest Information Update: 23 Jul 2012

At a glance

  • Drugs Risperidone (Primary)
  • Indications Autistic disorder
  • Focus Pharmacogenomic; Therapeutic Use
  • Most Recent Events

    • 23 Jul 2012 Additional lead trial centre identified as reported by ClinicalTrials.gov.
    • 23 Jul 2012 Actual patient number changed from 54 to 49 as reported by ClinicalTrials.gov.
    • 19 Nov 2010 Additional lead trial investigator and centre identified as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top